Sort
78,016 grants matching “breast cancer”
Tamoxifen &Second Breast Cancer: Epidemiology/Pathology
$695,014Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Combined breast MRI/biomarker strategies to identify aggressive biology
$695,009Victoria L. Seewaldt · Beckman Research Institute/City Of Hope · U01 · FY2017 · CA
Deciphering the structural determinants of response and resistance to HER2-targeted antibody-drug conjugates and tyrosine kinase inhibitors for HER2-mutant Non-Small Cell Lung Cancer
$695,004John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · University Of Utah · R01 · FY2024 · AI
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
INNOVATIVE IMMUNOTHERAPEUTICS FOR BREAST CANCER TREATMENT
$694,987University Of North Carolina At Chapel Hill · · FY2025 · Defense Health Agency
Integrating Tobacco Treatment into Cancer Care
$694,888Elyse R Park · Massachusetts General Hospital · R01 · FY2016 · CA
"Patient Navigation in the SafetyNet: CONNECTeDD"
$694,848Karen Freund · Boston Medical Center · U01 · FY2008 · CA
Immobilized Drug Transporters
$694,805Irving William Wainer · National Institute On Aging · Z01 · FY2008 · AG
Role of necrosis in the evolution of highly metastatic and chemo-resistant breast cancers
$694,795Kevin Jon Cheung · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
SPECTRUM (Studying PRIDE to Enhance Cancer screening guidelines for TRansgender Users of gender-affirMing hormones)
$694,771Lauren C Houghton · Columbia University Health Sciences · R01 · FY2024 · CA
Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer
$694,745Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2022 · CA
A new radiopharmaceutical for the treatment of metastatic bone cancer
$694,709Jaime Nmn Simon · Isotherapeutics Group, Llc · R44 · FY2013 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$694,705Mount Sinai Medical Center (Miami Beach) · U10 · FY2002 · CA
Stroger Hospital of Cook County, MBCCOP
$694,625Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2012 · CA
OSUCCC CUSP2CT
$694,575Electra D. Paskett · Ohio State University · U01 · FY2023 · CA
Genome-wide association study of breast cancer in high-risk women
$694,573Christopher Alan Haiman · University Of Southern California · R01 · FY2014 · CA
TARGETING PROLIFERATIVE AND DRUG RESISTANCE PATHWAYS IN TRIPLE-NEGATIVE BREAST CANCER STEM CELLS
$694,566Icahn School Of Medicine At Mount Sinai · · FY2017 · Department of the Army
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer
$694,368Neil Mukund Iyengar · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$694,319Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2021 · CA
Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer
$694,317Neil Mukund Iyengar · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care
$694,312Tara Olive Henderson · University Of Chicago · R01 · FY2021 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$694,227Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
The NYU Women's Health Study
$694,206Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2017 · CA
Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis
$694,114Heide L Ford · University Of Colorado Denver · R01 · FY2020 · CA